APA

Chedid P., Boussetta T., Dang P. M., Belambri S. A., Marzaioli V., Fasseau M., Walker F., Couvineau A., El-Benna J. & Marie J. (20171107). Vasoactive intestinal peptide dampens formyl-peptide-induced ROS production and inflammation by targeting a MAPK-p47. : Mucosal immunology.

Chicago

Chedid P, Boussetta T, Dang P M-C, Belambri S A, Marzaioli V, Fasseau M, Walker F, Couvineau A, El-Benna J and Marie J-C. 20171107. Vasoactive intestinal peptide dampens formyl-peptide-induced ROS production and inflammation by targeting a MAPK-p47. : Mucosal immunology.

Harvard

Chedid P., Boussetta T., Dang P. M., Belambri S. A., Marzaioli V., Fasseau M., Walker F., Couvineau A., El-Benna J. and Marie J. (20171107). Vasoactive intestinal peptide dampens formyl-peptide-induced ROS production and inflammation by targeting a MAPK-p47. : Mucosal immunology.

MLA

Chedid P, Boussetta T, Dang P M-C, Belambri S A, Marzaioli V, Fasseau M, Walker F, Couvineau A, El-Benna J and Marie J-C. Vasoactive intestinal peptide dampens formyl-peptide-induced ROS production and inflammation by targeting a MAPK-p47. : Mucosal immunology. 20171107.